BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29572028)

  • 1. Back to the future - The integration of big data with machine learning is re-establishing the importance of predictive correlations in ovarian cancer diagnostics and therapeutics.
    McDonald JF
    Gynecol Oncol; 2018 May; 149(2):230-231. PubMed ID: 29572028
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of genome research in the diagnosis and therapy of ovarian cancer].
    Malek AV; Bakhidze EV
    Vopr Onkol; 2005; 51(2):182-6. PubMed ID: 16222997
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical value of tumour markers in the management of ovarian cancer.
    Rustin GJ
    Ann Clin Biochem; 1996 Jul; 33 ( Pt 4)():284-9. PubMed ID: 8836386
    [No Abstract]   [Full Text] [Related]  

  • 4. The importance of test positive predictive value in ovarian cancer screening.
    Greene MH; Feng Z; Gail MH
    Clin Cancer Res; 2008 Nov; 14(22):7574; author reply 7577-9. PubMed ID: 18948386
    [No Abstract]   [Full Text] [Related]  

  • 5. The objectivity of reports describing the use of novel diagnostic tests in the management of ovarian cancer: a critique.
    Markman M
    Gynecol Oncol; 2007 Feb; 104(2):271-2. PubMed ID: 17258042
    [No Abstract]   [Full Text] [Related]  

  • 6. Machine learning, statistical learning and the future of biological research in psychiatry.
    Iniesta R; Stahl D; McGuffin P
    Psychol Med; 2016 Sep; 46(12):2455-65. PubMed ID: 27406289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and ascites neutralizing antibodies in ovarian cancer patients treated with intraperitoneal adenoviral gene therapy.
    Hemminki A; Wang M; Desmond RA; Strong TV; Alvarez RD; Curiel DT
    Hum Gene Ther; 2002 Aug; 13(12):1505-14. PubMed ID: 12215271
    [No Abstract]   [Full Text] [Related]  

  • 8. Hereditary breast-ovarian cancer: how can we use the new DNA markers to improve patient management?
    Narod S
    Clin Invest Med; 1993 Aug; 16(4):314-7. PubMed ID: 8306541
    [No Abstract]   [Full Text] [Related]  

  • 9. Big Data and Machine Learning in Health Care.
    Beam AL; Kohane IS
    JAMA; 2018 Apr; 319(13):1317-1318. PubMed ID: 29532063
    [No Abstract]   [Full Text] [Related]  

  • 10. Ovarian cancer: a bright future.
    Wenham RM
    Cancer Control; 2011 Jan; 18(1):4-5. PubMed ID: 21273974
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.
    Hermsen BB; von Mensdorff-Pouilly S; Berkhof J; van Diest PJ; Gille JJ; Menko FH; Blankenstein MA; Kenemans P; Verheijen RH
    J Clin Oncol; 2007 Apr; 25(11):1383-9. PubMed ID: 17416858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of core cancer genes using a hybrid of feature selection and machine learning methods.
    Liu YX; Zhang NN; He Y; Lun LJ
    Genet Mol Res; 2015 Aug; 14(3):8871-82. PubMed ID: 26345818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic patterns in serum and identification of ovarian cancer.
    Pearl DC
    Lancet; 2002 Jul; 360(9327):169-70; author reply 170-1. PubMed ID: 12126843
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction: the 12th Biennial Rivkin Center Ovarian Cancer Research Symposium.
    Maihle NJ; Levine DA; Dhillon K; Armstrong DK
    Int J Gynecol Cancer; 2019 Aug; 29(Suppl 2):s1. PubMed ID: 31462540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Big Data and Predictive Analytics: Recalibrating Expectations.
    Shah ND; Steyerberg EW; Kent DM
    JAMA; 2018 Jul; 320(1):27-28. PubMed ID: 29813156
    [No Abstract]   [Full Text] [Related]  

  • 17. Proteomic patterns in serum and identification of ovarian cancer.
    Rockhill B
    Lancet; 2002 Jul; 360(9327):169; author reply 170-1. PubMed ID: 12126842
    [No Abstract]   [Full Text] [Related]  

  • 18. [Future of use of molecular techniques in diagnosis and treatment of ovarian cancer].
    Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):193-4. PubMed ID: 12956121
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid mass spectrometric metabolic profiling of blood sera detects ovarian cancer with high accuracy.
    Zhou M; Guan W; Walker LD; Mezencev R; Benigno BB; Gray A; Fernández FM; McDonald JF
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2262-71. PubMed ID: 20699376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial ovarian cancer: future prospects for treatment.
    Shelling AN; Cooke IE; Le Meuth VG; Ganesan TS
    N Z Med J; 1996 Apr; 109(1020):131-2. PubMed ID: 8649666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.